Clinical trials: Obesity &Amp; Overweight
Obesity &Amp; Overweight
UBT251 Injection Phase II Study (Overweight or Obesity)
This randomized, double-blind, parallel, placebo-controlled phase II study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients
- Trial name
- NCT07177469
- Where
- China
- Volunteers
- 205 people
- Sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.
Stroke, Obesity &Amp; Overweight
Fueling Strong Hearts for a Strong South Carolina
South Carolina is home to many survivors of stroke. After leaving the hospital and finishing therapies, stroke survivors often do not have the supports they need to fully recover.
- Trial name
- NCT07140952
- Testing
- Strong SC, StrongPeople StrongHearts
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Clemson University
Obesity &Amp;Amp;Amp; Overweight, Environmental Exposure
Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity
The goal of this study is to examine the relationship in individuals with overweight/obesity and endocrine disrupting chemical (EDC) exposure through a two-armed, randomized clinical trial.
- Conditions
- Obesity &Amp;Amp;Amp; Overweight, Environmental Exposure, Overweight (BMI > 25)
- Trial name
- LiveWell (NCT07560579)
- Testing
- Educational curriculum, Weight loss Application, Urinary EDC metabolite testing
- Where
- United States
- Volunteers
- 226 people
- Sponsor
- Million Marker Wellness, Inc.